SN
Subbu Nambi
#173 out of 1697 analysts
Guggenheim
Automatically Tracked
Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
Gain and growth charts are calculated per selected timeframe:
63.97%
Gain +0.25%
Monthly
1.58%
Yearly
20.78%
Drawdown
35.68%
$163,972.23
Equity
Holdings
$163,972.23
Cash
$0
Investment
$151,171.58
$63,972.23
Profit +$407.86
Realized
$48,547.45
Unrealized
$15,424.78
Dividends
$33.91
$0
Cash
Deposits
$100,000
Withdrawals
$0
Commissions
$0
Goals
Avg. 0% completed goals
Today
Compared To Yesterday
Gain
0.25%
Profit
$407.86
Win %
72%
This Week
Compared To Last Week
Gain
0.2%
Profit
$318.63
Win %
72%
This Month
Compared to last month
Gain
-11.06%
Profit
-$20,058.84
Win %
80%
This Year
Compared to last year
Gain
37.65%
Profit
$44,130.76
Win %
62%
BRKR Bruker Corporation
+4.76%
+$608.38 
BLLN BillionToOne, Inc.
+4.42%
+$556.54 
WAT Waters Corporation
+3.42%
+$435.23 
TWST Twist Bioscience Corporation
+2.32%
+$271.13 
WGS GeneDx Holdings Corp.
+2.21%
+$272.02 
ILMN Illumina, Inc.
+1.85%
+$233.69 
DHR Danaher Corporation
+1.31%
+$183.02 
CYRX Cryoport Inc.
+0.13%
+$15.48 
VCYT Veracyte Inc.
+0.07%
+$8.76 Events
Loading...
Dividends
Dividend Analysis
Loading...
No Data
| Trades 572 | Longs Won 293/572 51% | Profit Factor 1.61 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1,401.52 |
| Average Win $576.76 | Best Trade (Jun 29) $19,870.44 | Sharpe Ratio -273.91 |
| Average Loss -$376.53 | Worst Trade (Oct 05) -$7,090.73 | Z-Score -3.88 (100%) |
| Commissions $0 | Avg. Trade Length 2m 3d | Expectancy $111.84 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.13% | 1.58% | 14.1% |
| Consecutive Losing Trades | 436 | 392 | 348 | 305 | 261 | 218 | 174 | 131 | 87 | 44 |
Hover over the desired column for a detailed explanation.
Returns
Overall, Monthly| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
 ADPT Adaptive Biotechnologies Corporation | 578.95 | $11,613.67 | $13,037.92 | - | $1,424.25 | 12.26% | -0.089% |
| BLLN BillionToOne, Inc. | 98.33 | $10,047.9 | $13,140.56 | - | $3,092.66 | 30.78% | +4.423% |
| BRKR Bruker Corporation | 212.72 | $10,941.16 | $13,382.24 | - | $2,441.08 | 22.31% | +4.763% |
| CYRX Cryoport Inc. | 773.93 | $11,246.58 | $11,740.51 | - | $493.93 | 4.39% | +0.132% |
| DHR Danaher Corporation | 70.94 | $12,707.92 | $14,122.43 | - | $1,414.51 | 11.13% | +1.313% |
 GH Guardant Health Inc. | 84.3 | $12,995.4 | $12,106.87 | - | -$888.53 | -6.84% | -1.272% |
| ILMN Illumina, Inc. | 66.58 | $11,567.12 | $12,848.4 | - | $1,281.28 | 11.08% | +1.853% |
 NTRA NATERA INC (Common Stock) – ticker 45E | 48.1 | $13,114.28 | $12,130.77 | - | -$983.51 | -7.5% | -2.252% |
 TEM Tempus AI, Inc. | 270.61 | $14,433.51 | $11,609.24 | - | -$2,824.27 | -19.57% | -0.023% |
| TWST Twist Bioscience Corporation | 134.89 | $8,435.03 | $11,944.45 | - | $3,509.42 | 41.61% | +2.323% |
| VCYT Veracyte Inc. | 219.06 | $10,026.2 | $12,190.93 | - | $2,164.73 | 21.59% | +0.072% |
| WAT Waters Corporation | 34.27 | $12,615.73 | $13,156.17 | - | $540.44 | 4.28% | +3.421% |
| WGS GeneDx Holdings Corp. | 203 | $8,802.96 | $12,561.76 | - | $3,758.8 | 42.7% | +2.213% |
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
